Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives

American Journal of Tropical Medicine and Hygiene

Volumn 60, Issue 4, 1999, Pages 547-555

  Price, Ric ^a,b,c   Van Vugt, Michelle ^a,b,d   Phaipun, Lucy ^a   Luxemburger, Christine ^a,b,c   Simpson, Julie ^b,c   McGready, Rose ^a,b,c   Ter Kuile, Feiko ^a,d   Kham, Am ^a   Chongsuphajaisiddhi, Tan Tan ^b   White, Nicholas J ^b,c   Nosten, François ^a,b,c  

^a SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER; ARTEMISIN DERIVATIVE; ARTESUNATE; MEFLOQUINE;

ADOLESCENT; ADULT; ANOREXIA; ARTICLE; BLOOD SMEAR; CARDIOTOXICITY; CHILD; CONTROLLED STUDY; DOSE RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; ELECTROCARDIOGRAM; FEMALE; HEMOGLOBINURIA; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; NAUSEA; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PLASMODIUM FALCIPARUM; PROSPECTIVE STUDY; SEIZURE; THAILAND; URTICARIA; VERTIGO; VOMITING;

EID: 0032960336     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1999.60.547     Document Type: Article

References (25)

1. Qinghaosu Antimalaria Coordinating Group, 1979. Antimalarial studies on qinghaosu. Chin Med J 92: 811-816.
2. China Cooperative Research Group, 1982. Studies on the toxicity of qinghaosu and its derivatives. J Tradit Chin Med 2: 31-38.
3. Hien TT, White NJ, 1993. Qinghaosu. Lancet 341: 603-608.
4. White NJ, 1992. Antimalarial drug resistance: the pace quickens. J Antimicrob Chemother 30: 71-85.
5. Nosten F, 1994. Artemisinin: large community studies. Trans R Soc Trop Med Hyg 88 (suppll): 45-46.
6. Nosten F, Luxemburger C, ter Kuile FO, Woodrow C, Pa Eh J, Chongsuphajaisiddhi T, White NJ, 1994. Treatment of multi-drug resistant Plasmodium falciparum malaria with a 3-day artesunate mefloquine combination. J Infect Dis 170: 971-977.
7. ter Kuile FO, Dolan G, Nosten F, Edstein MD, Luxemburger C, Phaipun L, Chongsuphajaisiddhi T, Webster HK, White NJ, 1993. Halofantrine versus mefloquine in the treatment of multi-drug resistant falciparum malaria. Lancet 341: 1044-1049.
8. Luxemburger C, ter Kuile FO, Nosten F, Dolan G, Bradol JH, Phaipun L, Chongsuphajaisiddhi T, White NJ, 1994. Single day mefloquine-artesunate combination in the treatment of multi-drug resistant falciparum malaria. Trans R Soc Trop Med Hyg 88: 213-217.
9. ter Kuile FO, Nosten F, Luxemburger C, Kyle D, Teja-Isava-tharm P, Phaipun L, Price RN, Chongsuphajaisiddhi T, White NJ, 1995. Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3,673 patients. Bull World Health Organ 73: 631-642.
10. Price RN, Nosten F, Luxemburger C, Am Kham, Brockman A, Chongsuphajaisiddhi T, White NJ, 1995. Artesunate versus artemether in combination with mefloquine for the treatment of multidrug resistant falciparum malaria. Trans R Soc Trop Med Hyg 89: 523-527.
11. Price RN, Luxemburger C, van Vugt M, Simpson J, Phaipun L, Chongsuphajaisiddhi T, Nosten F, White NJ, 1998. Treatment of uncomplicated hyperparasitaemic falciparum malaria on the Thai-Burmese border. Trans R Soc Trop Med Hyg 92: 207-211.
12. Price RN, van Vugt M, Nosten F, Luxemburger C, Brockman A, Phaipun L, Chongsuphajaisiddhi T, White NJ, 1998. Artesunate versus artemether for the treatment of recrudescent multi-drug-resistant falciparum malaria. Am J Trop Med Hyg 59: 883-888.
13. Luxemburger C, Nosten F, Shotar Raimond D, Chongsuphajaisiddhi T, White NJ, 1995. Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria. Am J Trop Med Hyg 53: 522-525.
14. LuxemburgerC, Kyaw Lay Thwai, White NJ, Webster HK, Kyle DE, Maelankirri L, Chongsuphajaisiddhi T, Nosten F, 1996. The epidemiology of malaria in a Karen population on the western border of Thailand. Trans R Soc Trop Med Hyg 90: 105-111.
15. World Health Organization, Division of Control of Tropical Diseases, 1990. Severe and complicated malaria. Trans R Soc Trop Med Hyg 84 (suppl 2): 1-65.
16. Li GQ, Guo XB, Jin R, Wang ZC, Jian HX, Li ZY, 1982. Clinical studies on treatment of cerebral malaria with qinghaosu and its derivatives. J Tradit Chin Med 2: 125-130.
17. Shen JX, 1989. Antimalarial Drug Development in China. Beijing: National Institute of Pharmaceutical Research and Development, on behalf of the UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases, 31-95.
18. Guo XB, Fu LC, Jian HX, Li GQ, Wang XH. 1994. Clinical trials of artemisinin and its derivatives in the treatment of malaria in China. Trans R Soc Trop Med Hyg 88 (suppl 1): 5-6.
19. White NJ, 1998. Preventing antimalarial drug resistance through combinations. Drug Res Updates 1: 3-8.
20. White NJ, 1997. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob Agents Chemother 41: 1413-1422.
21. Brewer TG, Peggins JO, Grate SJ, Petras JM, Levine BS, Weina PJ, Swearengen J, Heiffer MH, Schuster BG, 1994. Neurotoxicity in animals due to arteether and artemether. Trans R Soc Trop Med Hyg 88 (suppl 1): 33-36.
22. Nontprasert A, Nosten-Bertrand M, Pukrittayakamee S, Vanijanonta S, Angus BJ, White NJ, 1998. Assessment of the neurotoxicity of parenteral artemisinin derivatives in mice. Am J Trop Med Hyg 59: 519-522.
23. Miller LG, Panosian CB, 1997. Ataxia and slurred speech after artesunate treatment for falciparum malaria. New Engl J Med 336: 1328.
24. Chau THH, Day NPJ, Chuong LV, Mai NTH, Loc PP, Phu NH, Bethell DB, Sinh DX, Hien TT, White NJ, 1996. Blackwater fever in Southern Vietnam. A prospective descriptive study of 50 cases. Clin Infect Dis 23: 1274-1281.
25. Hien TT, Day NPJ, Phu NH, Mai NT, Chau TT, Loc PP, Sinh DX, Chuong LV, Vinh H, Waller D, Peto TEA, White NJ, 1996. Controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. New Eng J Med 335: 76-83.